DYDX Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds.
AI & Machine LearningBiotechDeep Tech
Andrew Králíček(Founder & Chief Technology Officer)inJonathan Good(Chief Executive Officer)inColm Carraher(Chief Scientific Officer)inNikki Lorigan(Chief Financial Officer)
Co-investorsBooster Innovation FundSproutFinistere VenturesIcehouse VenturesOurCrowdToyota Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.